sumatriptan has been researched along with Analgesic Overuse Headache in 11 studies
Sumatriptan: A serotonin agonist that acts selectively at 5HT1 receptors. It is used in the treatment of MIGRAINE DISORDERS.
sumatriptan : A sulfonamide that consists of N,N-dimethyltryptamine bearing an additional (N-methylsulfamoyl)methyl substituent at position 5. Selective agonist for a vascular 5-HT1 receptor subtype (probably a member of the 5-HT1D family). Used (in the form of its succinate salt) for the acute treatment of migraine with or without aura in adults.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sprague Dawley rats were administered six doses of lasmiditan (10 mg/kg), sumatriptan (10 mg/kg), or sterile water orally over 2 weeks and cutaneous allodynia was evaluated regularly in the periorbital and hindpaw regions using von Frey filaments." | 3.96 | Evaluation of LY573144 (lasmiditan) in a preclinical model of medication overuse headache. ( Aurora, SK; Dodick, DW; Johnson, KW; Navratilova, E; Oyarzo, J; Porreca, F; Rau, JC; Schwedt, TJ, 2020) |
| "Sumatriptan elicited cutaneous allodynia in both cephalic and hindpaw regions; cutaneous allodynia resolved to baseline levels after cessation of drug administration (14 days)." | 3.96 | Ubrogepant does not induce latent sensitization in a preclinical model of medication overuse headache. ( Banerjee, P; Behravesh, S; Dodick, DW; Navratilova, E; Oyarzo, J; Porreca, F, 2020) |
| "Headache associated with the chronic use of medications has become a significant problem in the management of headache." | 2.43 | [Medication-overuse headache]. ( Katsarava, Z; Rabe, K, 2006) |
| "Medication overuse headache was modeled by repeated sumatriptan administration in male and female mice." | 1.72 | A prolactin-dependent sexually dimorphic mechanism of migraine chronification. ( Dodick, DW; Ikegami, D; Khanna, R; Kopruszinski, CM; Moutal, A; Navratilova, E; Patwardhan, A; Porreca, F; Yue, X, 2022) |
| "Morphine was more detrimental than sumatriptan, consistent with clinical observations of higher medication overuse headache risk with opioids." | 1.51 | Sustained exposure to acute migraine medications combined with repeated noxious stimulation dysregulates descending pain modulatory circuits: Relevance to medication overuse headache. ( Dodick, DW; Nation, KM; Navratilova, E; Porreca, F, 2019) |
| "Eligible respondents had ICHD-3-beta migraine, reported ≥3 monthly headache days (MHDs) in the past 3 months, ≥1 MHD in the past 30 days, and currently took acute headache medication." | 1.48 | Factors associated with acute medication overuse in people with migraine: results from the 2017 migraine in America symptoms and treatment (MAST) study. ( Alam, A; Buse, DC; Dodick, DW; Fanning, KM; Lipton, RB; Munjal, S; Reed, ML; Schwedt, TJ, 2018) |
| "41." | 1.46 | Clinical characteristics and overuse patterns of medication overuse headache: Retrospective case-series study. ( Kluonaitis, K; Petrauskiene, E; Ryliskiene, K, 2017) |
| "Cutaneous allodynia (CA) was used as an outcome measure and CGRP blood and cerebrospinal fluid (CSF) levels were measured." | 1.46 | Prevention of stress- or nitric oxide donor-induced medication overuse headache by a calcitonin gene-related peptide antibody in rodents. ( Bigal, M; Chichorro, JG; Dodick, D; Eyde, NM; Kopruszinski, CM; Porreca, F; Remeniuk, B; Stratton, J; Walter, S; Xie, JY, 2017) |
| "Sumatriptan or saline was delivered subcutaneously by osmotic minipump for six days to Sprague-Dawley rats." | 1.40 | Increased susceptibility to cortical spreading depression in an animal model of medication-overuse headache. ( De Felice, M; Dodick, D; Green, AL; Gu, P; Ossipov, MH; Porreca, F, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 3 (27.27) | 2.80 |
| Authors | Studies |
|---|---|
| Ikegami, D | 1 |
| Navratilova, E | 4 |
| Yue, X | 1 |
| Moutal, A | 1 |
| Kopruszinski, CM | 2 |
| Khanna, R | 1 |
| Patwardhan, A | 1 |
| Dodick, DW | 5 |
| Porreca, F | 6 |
| Rau, JC | 1 |
| Oyarzo, J | 2 |
| Johnson, KW | 1 |
| Aurora, SK | 1 |
| Schwedt, TJ | 2 |
| Behravesh, S | 1 |
| Banerjee, P | 1 |
| Kluonaitis, K | 1 |
| Petrauskiene, E | 1 |
| Ryliskiene, K | 1 |
| Alam, A | 1 |
| Reed, ML | 1 |
| Fanning, KM | 1 |
| Munjal, S | 1 |
| Buse, DC | 1 |
| Lipton, RB | 1 |
| Nation, KM | 1 |
| Green, AL | 1 |
| Gu, P | 1 |
| De Felice, M | 1 |
| Dodick, D | 2 |
| Ossipov, MH | 1 |
| Cady, RK | 1 |
| Xie, JY | 1 |
| Eyde, NM | 1 |
| Remeniuk, B | 1 |
| Walter, S | 1 |
| Stratton, J | 1 |
| Bigal, M | 1 |
| Chichorro, JG | 1 |
| Rabe, K | 1 |
| Katsarava, Z | 1 |
| Ducros, A | 1 |
3 reviews available for sumatriptan and Analgesic Overuse Headache
| Article | Year |
|---|---|
Red flags and comfort signs for ominous secondary headaches.
Topics: Adult; Cooperative Behavior; Diagnosis, Differential; Diagnostic Imaging; Female; Headache Disorders | 2014 |
[Medication-overuse headache].
Topics: Acute Disease; Analgesics; Analgesics, Non-Narcotic; Chronic Disease; Ergotamine; Female; Headache; | 2006 |
[Acute and chronic headaches].
Topics: Acetaminophen; Adult; Aged; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Aspir | 2006 |
8 other studies available for sumatriptan and Analgesic Overuse Headache
| Article | Year |
|---|---|
A prolactin-dependent sexually dimorphic mechanism of migraine chronification.
Topics: Animals; Female; Headache Disorders, Secondary; Humans; Hyperalgesia; Male; Mice; Migraine Disorders | 2022 |
Evaluation of LY573144 (lasmiditan) in a preclinical model of medication overuse headache.
Topics: Analgesics; Animals; Benzamides; Central Nervous System Sensitization; Disease Models, Animal; Heada | 2020 |
Ubrogepant does not induce latent sensitization in a preclinical model of medication overuse headache.
Topics: Analgesics; Animals; Central Nervous System Sensitization; Disease Models, Animal; Female; Headache | 2020 |
Clinical characteristics and overuse patterns of medication overuse headache: Retrospective case-series study.
Topics: Adult; Analgesics; Analgesics, Opioid; Female; Headache Disorders; Headache Disorders, Secondary; Hu | 2017 |
Factors associated with acute medication overuse in people with migraine: results from the 2017 migraine in America symptoms and treatment (MAST) study.
Topics: Adolescent; Adult; Aged; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Cross-Sectiona | 2018 |
Sustained exposure to acute migraine medications combined with repeated noxious stimulation dysregulates descending pain modulatory circuits: Relevance to medication overuse headache.
Topics: Analgesics; Analgesics, Opioid; Animals; Headache Disorders, Secondary; Hyperalgesia; Male; Migraine | 2019 |
Increased susceptibility to cortical spreading depression in an animal model of medication-overuse headache.
Topics: Afferent Pathways; Animals; Cortical Spreading Depression; Disease Models, Animal; Electric Stimulat | 2014 |
Prevention of stress- or nitric oxide donor-induced medication overuse headache by a calcitonin gene-related peptide antibody in rodents.
Topics: Animals; Antibodies, Monoclonal; Calcitonin Gene-Related Peptide; Headache Disorders, Secondary; Hyp | 2017 |